Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of North University, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving North University patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving North University: Texas Weight Loss - North Austin, Slim Up Austin and Bio-X Weight Loss Center (Austin). Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Tirzepatide seen from North University, without the jargon. Sold as Mounjaro for diabetes and Zepbound for weight loss, tirzepatide stands out for its unique dual-hormone mechanism.
Manufacturer savings cards and coupons exist for the brands, but eligibility depends on insurance status and indication. Without insurance coverage, the brand-name price climbs fast; that is what pushes most patients to compare subscription programs that bundle the medication, monitoring, and delivery.
Tirzepatide belongs to the 'Dual GIP + GLP-1 agonist (first twincretin molecule)' class and is given as a weekly subcutaneous injection. The area's median income (~$86,556) weighs on the brand-vs-compounded trade-off in North University. In this state, Texas Occupations Code §111.001; the reference body is Texas Medical Board. Around North University in Travis County, 3 weight-management practice(s) are listed locally.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.